Based on the data and results of this study, overexpression of NCL inhibits the glucose metabolism activity of CD8+ T cells, thereby weakening their anti-tumor immune effects in the tumor microenvironment, consequently accelerating the growth and development of lung adenocarcinoma. The gene discussed is CD8A; the disease is neoplasm.